Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Endoscopic Application of a Novel Therapy for Duodenal Mucosal Regeneration in the Treatment of Type II Diabetes

NCT05014204 is registered in ClinicalTrials.gov with Endogenex, Inc. as lead sponsor.

NCT NCT05014204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05014204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Endoscopic Application of a Novel Therapy for Duodenal Mucosal Regeneration in the Treatment of Type II Diabetes
Lead sponsor
Endogenex, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 29, 2021
Completion date
May 29, 2025
Enrollment
20 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, diabetes mellitus, type 2, diabetes type 2, endocrine system diseases, glucose metabolism disorders, metabolic disease